Further studies are needed to understand the role of newly associated variants with PSP including the effect of SLCO1A2 variation in BBB function in PSP and the cis and trans regulatory effects of GWAS variants on gene networks associated with tauopathy. The gene discussed is SLCO1A2; the disease is supranuclear palsy, progressive, 1.